Part 2: Interpreting and Reporting Abnormal F-18 Flurpiridaz Studies

Part 2 of this series provides an in-depth discussion of 3 abnormal F-18 studies. For each case, the faculty will discuss uptake patterns, incidental findings, and normal variants seen with F-18 tracers and how they differ from existing cardiac PET tracers, and discuss interpreting myocardial blood flow measurements. A systematic approach to review these images will be described and look at how these PET MPI cases will help you serve your patients with the clinical information you need for your referring physicians.

To claim your CME credit and certificate, you must first watch the video and then complete the evaluation. To do this, click the “Get Started” or “Login” button. Please note, the button you see is dependent if you are currently logged in. Upon clicking this button, follow the cues to complete the evaluation, claim your credit and access your certificate.

This program is intended for nuclear cardiologists, multimodality imaging cardiologists, imaging technologists, cardiologists/interventionalists, nuclear medicine physicians, radiologists, and others interested in learning about the capabilities of F-18 flurpiridaz.

Upon completing this activity, learners should be able to:

Describe how to identify misregistration and the importance of minimizing patient motion
Identify utility of wall motion to avoid false positive studies

Evaluation Deadline: AMA PRA Category 1 Credits™- October 26, 2026. The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians: The American Society of Nuclear Cardiology designates this internet live activity for a maximum of .5 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of all financial relationships with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All persons who influenced the content of this activity are required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed these disclosures and mitigated or managed all identified conflicts of interest through a peer review process.

The following faculty, reviewers and ASNC staff who were involved in the planning and development of this activity reported no financial relationships:
Renée Bullock-Palmer, MD (Education Reviewer)
Linda Giering, PhD (ASNC Staff)
Dawn Edgerton (ASNC Staff)

Faculty who were involved in the planning and development of this activity reported the following financial relationships:
Mouaz Al-Mallah, MD, MSc, MASNC - Research Grants (Siemens; GE Healthcare); Consultant (Jubilant Radiopharma; MedTrace; Phillips; Pfizer)
Panithaya Chareonthaitawee, MD - Consultant (GE Healthcare); Royalties (UpToDate)
Timothy Bateman, MD, MASNC - Ownership – CVIT; Consultant – GEHC, Synektik; Research grants – Bracco, GEHC, Spectrum Dynamics
James Case, PhD, MASNC - Research grants – Bracco, GE, Spectrum Dynamics; Consultant – GE; Owner - CVIT
Marcelo Di Carli, MD, MASNC - Research Grants (Amgen (institutional); Gilead Sciences); Consultant (Bitterroot Bio; IBA; MedTrace; Sanofi; Sun Pharma; Valo Health)
Robert deKemp, PhD, MASNC - Royalty/research grant – Jubilant DraxImage; License revenue – INVIA Medical Solutions
Jamshid Maddahi, MD, MASNC - Consultant (GE Healthcare); Principal Investigator Flupiridaz Trials/Research Funding (GE Healthcare)
Piotr Slomka, PhD, MASNC - Software Royalties (Cedars-Sinai); Consultant (Synektik)
Prem Soman, MD, PhD, MASNC - Research grant – Pfizer; Consulting – Alnylam, Spectrum Dynamics, Eidos, Pfizer

Technical Advisor:
Jennifer Renaud, PhD - Employee (INVIA, LLC); Consultant (Jubilant Radiopharma)

Release Date: October 27, 2025
Expiration Date: October 26, 2026
After October 26, 2026, a fee will be charged to obtain your certificate.

This enduring material activiy requires listening to a lecture comprised of content on the topic discussed during webinars on January 23 and April 15, 2025 and then completing an evaluation. The information has been organized thematically for this purpose.

This activity is supported by an unrestricted educational grant from GE HealthCare.

American Society of Nuclear Cardiology
10300 Eaton Place, Suite 301
Fairfax, VA 22030
703-459-2555 | info@asnc.org | www.ASNC.org